8 results about "Steroid hormone" patented technology

The present application is applicable to the field of medical devices, and discloses a liquid chromatography-mass spectrometry apparatus and a control method for the liquid chromatography-mass spectrometry apparatus. The liquid chromatography-mass spectrometry apparatus comprises a sample storage device, a pretreatment device, a chromatography device, a mass spectrometry detection device, and a controller. The chromatography device comprises a test solution preparation channel, a test solution transfer assembly, a liquid phase fluid delivery assembly, and a chromatography column. An operating pressure outputted by the liquid phase fluid delivery assembly is less than or equal to 20 MPa. The length of the chromatography column is greater than or equal to 3 mm and less than or equal to 35 mm. A sample comprises a target substance to be measured, and the target substance to be measured comprises at least one of vitamin D, a steroid hormone, and a catecholamine. The present application reduces costs of the liquid chromatography-mass spectrometry apparatus.

The present disclosure relates to a method for detecting vitamin D or a steroid hormone and a blood sample pretreatment kit. The method for detecting vitamin D in blood comprises pretreating a blood sample to obtain a test sample, and detecting the test sample by liquid chromatography tandem mass spectrometry, wherein the pretreatment comprises: adding an internal standard solution and a magnetic bead reagent to the blood sample to obtain a mixed solution and incubating to allow the target analyte to bind to the surface of the magnetic beads; separating the magnetic beads combined with the target analyte; and eluting the target analyte from the surface of the magnetic beads to obtain the test sample, wherein the mixed solution comprises methanol in an amount of 45vol% to 60vol%, or ethanol in an amount of 30vol% to 50vol%. The method can significantly reduce non-specific adsorption of magnetic beads, and improve the accuracy and sensitivity of detection.

This invention discloses sterol side-chain cleaving enzymes and 3β-hydroxysteroid dehydrogenases / Δ from different sources. 4,5 Amino acid sequences, coding sequences, and applications of isomerases. This invention, based on synthetic biology and molecular pharmacognosy, explores sterol side-chain cleaving enzymes and 3β-hydroxysteroid dehydrogenases / Δ from different plant sources. 4,5 Isomerases, which will yield sterol side-chain cleavage enzymes and 3β-hydroxysteroid dehydrogenases / Δ 4,5 The coding sequences of the isomerases were constructed into expression cassettes, and using Saccharomyces cerevisiae as the chassis strain, highly efficient pregnenolone or progesterone synthesizing strains were obtained. The pregnenolone yield of the constructed strains reached as high as 14.46±2.16 mg / L, and the progesterone yield reached as high as 32.78±1.84 mg / L. This achieved high-level synthesis of pregnenolone and progesterone by genetic engineering methods, providing an important foundation for the green synthesis of steroid hormones.

This invention discloses the application of a ketone reductase mutant in the catalytic reduction reaction of steroid ketone compounds, belonging to the field of biocatalysis and enzyme engineering technology. The ketone reductase mutant is based on the amino acid sequence of the wild-type ketone reductase ChKRED20, and the following mutations are made: mutant ChKRED20-M4C3: S153L, Q97L, Y188G, and H145A; mutant ChKRED20-M4C5: S153L, Q97L, Y188A, and H145A. This invention provides mutants ChKRED20-M4C3 and ChKRED20-M4C5 that successfully achieve the efficient synthesis of steroid hormones, represented by testosterone. Through carrier-free immobilization technology, efficient recycling and reuse of the ketone reductase mutant are achieved. Based on this, a microfluidic bed is designed to realize the continuous flow production of testosterone.

This invention discloses a novel use of posaconazole to enhance the immune response in the immunotherapy of breast cancer. Specifically, this invention provides a drug combination comprising posaconazole and a PD-L1 inhibitor. The effects of this invention are: (1) using posaconazole to prepare a drug for treating breast cancer, especially triple-negative breast cancer (TNBC), achieving "repurposing of an old drug"; (2) clarifying its core mechanism of action, clarifying that the anti-tumor effect of clinically commonly used doses of posaconazole depends on the host immune system, rather than traditional direct cytotoxicity, specifically by inhibiting CYP11A1 and other related enzymes in the tumor, thereby reducing immunosuppressive steroid hormones, providing a new drug and target for tumor immunotherapy; (3) providing a technical solution for the combined treatment of posaconazole and PD-L1 inhibitors (such as anti-PD-L1 antibodies), further enhancing anti-tumor immunity and improving the treatment effect of TNBC.

Provided are an estimation device, an estimation method, and a program capable of estimating the steroid hormone concentration in the future from the point of time when data is measured. The estimation device estimates, by using an estimation model that receives physiological data at a certain point of time as an input and outputs an estimation value of the steroid hormone concentration after a prescribed time, a first steroid hormone concentration after a prescribed time by using first physiological data at a certain point of time. The estimation model is a model trained by using second physiological data for training at a certain point of time and a measurement value of a second steroid hormone concentration for training after a prescribed time.

The application discloses a 21-hydroxylase deficiency screening kit and application thereof, relates to the blood analysis technical field, and a steroid hormone marker composition of 21-hydroxylase deficiency, wherein the nine markers comprise 17alpha-hydroxyprogesterone, androstenedione, 11-deoxycortisol, 21-deoxycortisol, cortisol, corticosterone, progesterone, dihydrotestosterone and 11-deoxycorticosterone; the kit can be used for screening 21-hydroxylase deficiency, 11beta-hydroxylase deficiency, 17alpha-hydroxylase deficiency and other types of diseases; the kit comprises detection components for detecting the hormones; compared with a traditional time-resolved fluorescence immunoassay method, the LC-MS / MS multi-index combined detection scheme adopted in the application can significantly reduce false positive results; and invalid recall, unnecessary family anxiety and medical burden caused by false positive results are greatly reduced.

This invention discloses a method for detecting steroid hormones using furoyl chloride derivatization-liquid chromatography-tandem mass spectrometry. This invention utilizes furoyl chloride to derivatize steroid hormones, and the combination with liquid chromatography-tandem mass spectrometry enables highly sensitive and accurate quantification of trace amounts of steroid hormones such as estrone and estradiol in biological matrices. Compared with existing technologies, the method for detecting steroid hormones using furoyl chloride derivatization-liquid chromatography-tandem mass spectrometry provided by this invention exhibits high recovery, a wide linear range, good linearity, low detection limit, and mild reaction conditions with a simplified reaction procedure.